{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:47:30Z","timestamp":1785822450174,"version":"3.56.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To systematically analyze the project completion status and research characteristics in the field of Chinese Materia Medica (CMM, discipline code H32) funded by the National Natural Science Foundation of China (NSFC), thereby providing a basis for optimizing the allocation of scientific research resources and adjusting funding strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on the NSFC big database system, a retrospective analysis was conducted to descriptively analyze the research output, potential translational capacity, and research characteristics of completed projects in the CMM field funded by NSFC from 2015 to 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 2015 to 2024, a total of 4,574 projects in the CMM field were completed, with a compound annual growth rate (CAGR) of 3.0%. The cumulative total funding was 1.86 billion RMB, with an average of 410 KRMB per project. The average research output was 6.6 items per project, and the potential patent conversion ratio was 61%. For the first time, the 19 sub-directions within the CMM field were categorized into four echelons: double-high advantage, high-output low-conversion, low-output high-conversion, and Low-Output Low-Conversion areas. Key advantage areas included CMM pharmacodynamic substances, CMM resources, and ethnic pharmacology. Disease research primarily focused on cardiovascular and cerebrovascular diseases, tumors, metabolic diseases, and neurological disorders. Technical methodologies rapidly evolved from traditional chemical analysis to multi-omics and systems biology, while research mechanisms expanded towards multi-dimensional regulatory networks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NSFC funding for the CMM field has been consistently stable. The discipline demonstrates an overall trajectory characterized by deepening basic research, rapid iteration of technical methods, increasing diversification of research directions, and steadily improving translational potential. These findings provide data support and decision-making references for optimizing NSFC funding strategies in the CMM field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1908693","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:38:34Z","timestamp":1785821914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["NSFC-funded Chinese materia medica research (2015\u20132024): achievements output, research characteristics, and evolution"],"prefix":"10.3389","volume":"17","author":[{"given":"Hu","family":"Jin","sequence":"first","affiliation":[{"name":"Office of Scientific Research, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Can","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Hua","sequence":"additional","affiliation":[{"name":"Office of Scientific Research, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Qunli","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"B1","first-page":"753","article-title":"Research progress of supramolecular chemistry in Chinese materia medica based on NSFC-Funded projects","volume":"56","author":"Cai","year":"2025","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"B2","first-page":"211","article-title":"Review on application and funding of NSFC projects in active substances of Chinese materia medica in 2013","volume":"16","author":"Chen","year":"2014","journal-title":"World Sci. technol.-mod. Tradit. Chin. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacig.2022.07.004","article-title":"Research hotspot and frontier analysis of traditional Chinese medicine in asthma using bibliometric methods from 1991 to 2021","volume":"1","author":"Chen","year":"2022","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"B4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.19879\/j.cnki.1005-5304.202502116","article-title":"Application and progress of organ-on-a-chip technology in Chinese materia medica research","volume":"32","author":"Chen","year":"2025","journal-title":"Chin. J. Inf. Traditional Chin. Med."},{"key":"B5","first-page":"498","article-title":"Visualization analysis of current status, hotspots and trends of traditional Chinese medicine in carotid atherosclerosis based on CiteSpace and VOSviewer","volume":"27","author":"Chen","year":"2025","journal-title":"World Sci. technol.-mod. Tradit. Chin. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.13313\/j.issn.1673-4890.20240731003","article-title":"Research progress of self-assembled peptides delivering active ingredients of Chinese materia medica for anti-tumor, antibacterial and wound healing","volume":"28","author":"Chen","year":"","journal-title":"Mod. Chin. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.19540\/j.cnki.cjcmm.20260430.303","article-title":"Research progress of nano-delivery system of active ingredients from Chinese materia medica in the treatment of kidney diseases","author":"Chen","year":"","journal-title":"China J. Chin. Mater. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jtcms.2021.03.002","article-title":"Hospital-based health technology assessment: the next frontier for traditional Chinese medicine hospitals","volume":"8","author":"Dai","year":"2021","journal-title":"J. Tradit. Chin. Med. Sci."},{"key":"B9","first-page":"857","article-title":"Research progress of traditional Chinese medicine regulating intestinal flora in the treatment of non-alcoholic fatty liver disease based on \u201cgut-microbiota-liver axis\u201d","volume":"46","author":"Du","year":"2025","journal-title":"Shaanxi J. Traditional Chin. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.4268\/cjcmm20161932","article-title":"Analysis of funded and completed projects in Chinese materia medica resources supported by NSFC in recent three years. China J","volume":"41","author":"Gao","year":"2016","journal-title":"Chin. Mater. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13422\/j.cnki.syfjx.20260236","article-title":"Research progress of traditional Chinese medicine in the treatment of Parkinson\u2019s disease based on \u201cmicrobiota-gut-brain axis\u201d theory","author":"Gao","year":"2025","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"B12","first-page":"1415","article-title":"Analysis of funded projects in toxicology of Chinese materia medica supported by NSFC from 2012 to 2021. China J","volume":"47","author":"Han","year":"2022","journal-title":"Chin. Mater. Med."},{"key":"B13","first-page":"1729","article-title":"Research progress of tumor organoids in anti-tumor therapy of monomer components of Chinese materia medica","volume":"29","author":"Liu","year":"2025","journal-title":"Anhui Med. Pharm. J."},{"key":"B14","first-page":"1093","article-title":"Mechanism of traditional Chinese medicine in prevention and treatment of MAFLD from the perspective of organelle crosstalk","volume":"30","author":"Liu","year":"2025","journal-title":"Mod. Dig. and Intervention"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1360\/972011-1819","article-title":"Basic research competitiveness of provinces and cities in China: evidence from the national natural science foundation of China","volume":"56","author":"Ma","year":"2011","journal-title":"Sci. Bull."},{"key":"B16","volume-title":"National Natural Science Foundation of China Application Codes","year":"2020"},{"key":"B17","unstructured":"NSFC big data knowledge management service platform: data statistics [EB\/OL]\n          \n          \n          2025"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.13313\/j.issn.1673-4890.20240927001","article-title":"Research progress of AUF-LC\/MS in Chinese materia medica analysis in recent five years","volume":"27","author":"Ni","year":"2025","journal-title":"Mod. Chin. Med."},{"key":"B19","first-page":"1","article-title":"Research progress of active ingredients of Chinese materia medica regulating macrophage glycolysis reprogramming in metabolic diseases","author":"Niu","year":"2026","journal-title":"Lishizhen Med. Mater. Med. Res."},{"key":"B20","first-page":"307","article-title":"Statistical analysis of NSFC-Funded projects in Chinese materia medica from 2002 to 2011","volume":"26","author":"Peng","year":"2012","journal-title":"Bull. Natl. Nat. Sci. Found. China"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3736\/jcim20111001","article-title":"Analysis on application and funding of traditional Chinese medicine projects supported by NSFC in 2010. J. Chin. Integr","volume":"9","author":"Shang","year":"2011","journal-title":"Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.16153\/j.1002-7777.2022.01.012","article-title":"Research hotspots of Chinese materia medica and natural medicines in China based on scientometrics and visualization","volume":"36","author":"Shen","year":"2022","journal-title":"Chin. Pharm. Aff."},{"key":"B23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.16262\/j.cnki.1000-8217.2022.05.005","article-title":"Practice and thinking of NSFC reform on adjusting application codes to optimize disciplinary layout in the new era","volume":"36","author":"Sun","year":"2022","journal-title":"Bull. Natl. Nat. Sci. Found. China"},{"key":"B24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.19879\/j.cnki.1005-5304.202006096","article-title":"Funding status and research hotspots of Chinese materia medica identification supported by NSFC from 2010 to 2019","volume":"28","author":"Tan","year":"2021","journal-title":"Chin. J. Inf. Traditional Chin. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.4268\/cjcmm20160908","article-title":"Hotspots and trends of molecular pharmacognosy projects in Chinese materia medica (H28) funded by NSFC","volume":"41","author":"Wang","year":"2016","journal-title":"China J. Chin. Mater. Med."},{"key":"B26","first-page":"809","article-title":"Research progress of traditional Chinese medicine regulating ferroptosis in hematological malignancies","volume":"41","author":"Wei","year":"2025","journal-title":"Chin. J. Pathophysiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.14009\/j.issn.1672-2124.2023.09.002","article-title":"Analysis of funding and research hotspots of traditional Chinese medicine projects supported by the national natural science foundation of China from 2011 to 2020","volume":"23","author":"Wen","year":"2023","journal-title":"Eval. Analysis Drug Use Chin. Hosp."},{"key":"B28","first-page":"365","article-title":"Bibliometric analysis of research hotspots and trends in Chinese materia medica analysis","volume":"42","author":"Wu","year":"2025","journal-title":"Hebei J. Ind. Sci. Technol."},{"key":"B29","first-page":"5616","article-title":"Application and research progress of artificial intelligence in quality control of Chinese materia medica","volume":"56","author":"Xie","year":"2025","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.13422\/j.cnki.syfjx.20250391","article-title":"Research progress on mechanism of traditional Chinese medicine against hepatocellular carcinoma based on epigenetic regulation","volume":"30","author":"Xu","year":"2024","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"B31","first-page":"162","article-title":"Research progress of traditional Chinese medicine targeting intracellular redox balance to improve ferroptosis in hypertension","volume":"21","author":"Yang","year":"2026","journal-title":"World Chin. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3969\/j.issn.1001-8409.2013.12.019","article-title":"From transformation rate of scientific and technological achievements to transformation efficiency: indicator system design and empirical analysis","volume":"27","author":"Zhang","year":"2013","journal-title":"Soft Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.20251\/j.cnki.1003-3734.2025.10.012","article-title":"Research progress of biomimetic nano-drug delivery system of active ingredients from Chinese materia medica in liver diseases","volume":"34","author":"Zhang","year":"2025","journal-title":"Chin. J. New Drugs"},{"key":"B34","first-page":"1120","article-title":"Analysis on application and funding of traditional Chinese medicine research projects for chronic skin ulcers supported by NSFC during 2008\u20132022","volume":"31","author":"Zhao","year":"2025","journal-title":"Chin. J. Basic Med. Traditional Chin. Med."},{"key":"B35","first-page":"1537","article-title":"Research progress of modern nano-formulations of Chinese materia medica in cardiovascular diseases","volume":"24","author":"Zhao","year":"2026","journal-title":"Chin. J. Integr. Med. Cardio-Cerebrovasc. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1908693\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:38:47Z","timestamp":1785821927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1908693\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":35,"alternative-id":["10.3389\/fphar.2026.1908693"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1908693","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"1908693"}}